Data from: CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma

Li Li, Jing Yan, Jing Xu, Chao-Qun Liu, Zuo-Jun Zhen, Huan-Wei Chen, Yong Ji, Zhi-Peng Wu, Jian-Yuan Hu, Limin Zheng & Wan Yee Lau
CXC ligand 17 (CXCL17) is a novel CXC chemokine whose clinical significance remains largely unknown. In the present study, we characterized the prognostic value of CXCL17 in patients with hepatocellular carcinoma (HCC) and evaluated the association of CXCL17 with immune infiltration. We examined CXCL17 expression in 227 HCC tissue specimens by immunohistochemical staining, and correlated CXCL17 expression patterns with clinicopathological features, prognosis, and immune infiltrate density (CD4 T cells, CD8 T cells, B cells, natural...
1 citation reported since publication in 2015.
462 views reported since publication in 2015.

These counts follow the COUNTER Code of Practice, meaning that Internet robots and repeats within a certain time frame are excluded.
What does this mean?
99 downloads reported since publication in 2015.

These counts follow the COUNTER Code of Practice, meaning that Internet robots and repeats within a certain time frame are excluded.
What does this mean?